Cargando…

CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis

OBJECTIVE: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Qiliu, Lao, Xianjun, Tang, Weizhong, Chen, Zhiping, Li, Ruolin, Wang, Jian, Deng, Yan, Li, Taijie, Qin, Xue, Li, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912176/
https://www.ncbi.nlm.nih.gov/pubmed/24498403
http://dx.doi.org/10.1371/journal.pone.0087925
_version_ 1782302053737955328
author Peng, Qiliu
Lao, Xianjun
Tang, Weizhong
Chen, Zhiping
Li, Ruolin
Wang, Jian
Deng, Yan
Li, Taijie
Qin, Xue
Li, Shan
author_facet Peng, Qiliu
Lao, Xianjun
Tang, Weizhong
Chen, Zhiping
Li, Ruolin
Wang, Jian
Deng, Yan
Li, Taijie
Qin, Xue
Li, Shan
author_sort Peng, Qiliu
collection PubMed
description OBJECTIVE: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a meta-analysis of all available studies to investigate this association. METHODS: All studies published up to October 2013 on the association between CASP8 -652 6N ins/del polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between CASP8 -652 6N ins/del polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). RESULTS: Six studies with 6,325 cases and 6,842 controls were included in the meta-analysis. We observed that the CASP8 -652 6N ins/del polymorphism was significantly correlated with CRC risk when all studies were pooled into the meta-analysis (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.821–0.964, P = 0.004; del/del + ins/del vs. ins/ins: OR = 0.899, 95%CI 0.833–0.970, P = 0.006). In stratified analyses by ethnicity, source of control, and quality score, significant association was observed in Asians (ins/del vs. ins/ins: OR = 0.862, 95%CI 0.761–0.977, P = 0.020; del/del + ins/del vs. ins/ins: OR = 0.845, 95%CI 0.749–0.953, P = 0.006), population-based studies (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.813–0.975, P = 0.012; del/del + ins/del vs. ins/ins: OR = 0.901, 95%CI 0.827–0.982, P = 0.018), and high quality studies. However, in subgroup analysis according to cancer location, no significant association was detected. CONCLUSIONS: The present meta-analysis suggests that the CASP8 is a candidate gene for CRC susceptibility. The CASP8 -652 6N ins/del polymorphism may play a protective role in CRC development especially among Asians. Further large and well-designed studies are needed to confirm this association.
format Online
Article
Text
id pubmed-3912176
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39121762014-02-04 CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis Peng, Qiliu Lao, Xianjun Tang, Weizhong Chen, Zhiping Li, Ruolin Wang, Jian Deng, Yan Li, Taijie Qin, Xue Li, Shan PLoS One Research Article OBJECTIVE: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a meta-analysis of all available studies to investigate this association. METHODS: All studies published up to October 2013 on the association between CASP8 -652 6N ins/del polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between CASP8 -652 6N ins/del polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). RESULTS: Six studies with 6,325 cases and 6,842 controls were included in the meta-analysis. We observed that the CASP8 -652 6N ins/del polymorphism was significantly correlated with CRC risk when all studies were pooled into the meta-analysis (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.821–0.964, P = 0.004; del/del + ins/del vs. ins/ins: OR = 0.899, 95%CI 0.833–0.970, P = 0.006). In stratified analyses by ethnicity, source of control, and quality score, significant association was observed in Asians (ins/del vs. ins/ins: OR = 0.862, 95%CI 0.761–0.977, P = 0.020; del/del + ins/del vs. ins/ins: OR = 0.845, 95%CI 0.749–0.953, P = 0.006), population-based studies (ins/del vs. ins/ins: OR = 0.890, 95%CI 0.813–0.975, P = 0.012; del/del + ins/del vs. ins/ins: OR = 0.901, 95%CI 0.827–0.982, P = 0.018), and high quality studies. However, in subgroup analysis according to cancer location, no significant association was detected. CONCLUSIONS: The present meta-analysis suggests that the CASP8 is a candidate gene for CRC susceptibility. The CASP8 -652 6N ins/del polymorphism may play a protective role in CRC development especially among Asians. Further large and well-designed studies are needed to confirm this association. Public Library of Science 2014-02-03 /pmc/articles/PMC3912176/ /pubmed/24498403 http://dx.doi.org/10.1371/journal.pone.0087925 Text en © 2014 Peng et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Peng, Qiliu
Lao, Xianjun
Tang, Weizhong
Chen, Zhiping
Li, Ruolin
Wang, Jian
Deng, Yan
Li, Taijie
Qin, Xue
Li, Shan
CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis
title CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis
title_full CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis
title_fullStr CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis
title_full_unstemmed CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis
title_short CASP8 -652 6N Del Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Meta-Analysis
title_sort casp8 -652 6n del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912176/
https://www.ncbi.nlm.nih.gov/pubmed/24498403
http://dx.doi.org/10.1371/journal.pone.0087925
work_keys_str_mv AT pengqiliu casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT laoxianjun casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT tangweizhong casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT chenzhiping casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT liruolin casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT wangjian casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT dengyan casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT litaijie casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT qinxue casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis
AT lishan casp86526ndelpolymorphismcontributestocolorectalcancersusceptibilityevidencefromametaanalysis